Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Atai Life Sciences N.V. (ATAI)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
13.50+0.53 (+4.09%)
At close: 4:00PM EDT
13.65 +0.15 (+1.11%)
After hours: 07:50PM EDT
Advertisement
Sign in to post a message.
  • J
    Jay
    Does anyone know the lock-up schedule? IR never got back to me when I asked
    Neutral
  • V
    V
    Just bought the DIP. Been buying the DIP for the last month. HOLD.
  • J
    Jack
    Finally in after a year and half of waiting. I’m extra long so don’t mind if it goes down a little after the lock up and can buy more. $12 is a great starting position for my plans. Excited by ATAI, good luck to all
  • B
    Bobby Axelrod
    Considering taking a position in ATAI today. Has it bottom'd out? Can't imagine this going lower than $14.
    Bullish
  • M
    Mikey
    Buy and hold. Let’s go atai!
    Bullish
  • M
    Matt
    $IGXT conversation
    Loving the strategic partnerships that IGXT does - $ATAI, $CYBN and now Exeltis! This stock should be a $1. Way undervalued.
  • D
    DEREK
    This board is awfully quiet who can tell me what the most likely news that will propel this stock and sector ?
    Bullish
  • S
    Senor
    This will be at $40 one day…
  • B
    Bobby Axelrod
    This is at a great deal today. Anything below IPO opening price of $16 is a steal.
    Bullish
  • T
    TraderJoe
    Explain to me why I would invest in a company with a -8 EPS?
  • B
    Bob
    Back when I was treating opiate addiction with suboxone before I retired several years ago a couple of my patients had gone to the caribbean for ibogaine treatment. At that time it was available from a group that under the radar was using it for opiate addiction treatment-it was effective for up to a year in one case from a female patient taking all cravens away and desire for opiates for over a year-this patient came to me for suboxone and wished she could afford to go back there-she reported an intense the hallucigenic experience that required to stay for a while afterwards several days or a week in a protected environment-she later after more than a year clean time came to me after a relapse-and i heard of several reports of similar efficacy-so my impression was it is a powerful intermediate duration treatment at the proper dose -6-18 mos. but opiate addicts must combine it with recovery work habits so when the ffect wares off they can minimize relapse-if made legal in the right settings multiple re-dosing could conceivably facilitate long term recovery-however it remains to be seen if second or third dosing has as much of an enduring effect or whether it is a one and done for most people- side effects like suicide self harm or cognitive decline etc could occur when studying larger numbers-and people with co-occuring disorders like bipolar or schizophrenia may be triggered by ibogaine or bring out latent mania or psychosis in previously undiagnosed patients-therefore patient selection may become one of the challenges-probably so only a certain sub-population may safely benefit from ibogaine treatment -how do you develop the criteria for selection that will avoid potential pitfalls? Getting a valid prior drug use history of hallucinogens any prior adverse effects or mental health history etc. may not be enough to screen out people at high risk so desperate for help - many addicts would lie to get a chance and of course drug diversion and un-authorized use/abuse
    Neutral
  • M
    Mr. Buddah
    Adtx

    The magnificent one
  • V
    V
    Angermayer & Thiel need to take this to $60!
    Bullish
  • A
    Andrew
    Any reasons for the bump?
  • B
    Brett
    Look at that jump.
    Bullish
  • M
    Matt
    Gotta love the 5% increase after market!
  • A
    Alex
    Anyone who buys this stock before the lock up period expires is a fool. There will be huge insider selling in December. January or February is buying time for this company.
  • Y
    Yahoo Finance Insights
    Atai Life Sciences is up 7.12% to 15.80
  • Y
    Yahoo Finance Insights
    Atai Life Sciences is up 6.46% to 14.50
  • S
    Senor
    Holding since ipo, getting increasingly bullish, looking for some returns elsewhere to roll into this before it takes off
Advertisement
Advertisement